{"SPADE_N_07187": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07187", "Peptide Name": "Chemokinostatin-1", "Source": "CXCL1", "Family": "", "Gene": "Not found", "Sequence": "NGREACLDPEAPMVQKIVQKMLKG", "Sequence Length": 24, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "CXCR3", "Linear/Cyclic": "", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C113H195N33O34S3", "Mass": 2656.15, "PI": 8.18, "Net Charge": 1, "Hydrophobicity": -0.45, "Half Life": "Mammalian:1.4 hourYeast:3 minE.coli:>10 hour", "Literature": [{"Title": "Anti-angiogenic peptides for cancer therapeutics", "Pubmed ID": "21470139", "Reference": "Curr Pharm Biotechnol. 2011 Aug;12(8)1101-28.", "Author": "Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21470139"}], "Frequent Amino Acids": "KAE", "Absent Amino Acids": "FHOSTUWY", "Basic Residues": 4, "Acidic Residues": 3, "Hydrophobic Residues": 11, "Polar Residues": 12, "Positive Residues": 4, "Negative Residues": 3, "Similar Sequences": [{"SPADE_ID": "SPADE_N_09971", "Similarity": 0.6428571428571429, "Sequence": "APRIKKIVQKKLAGD"}, {"SPADE_ID": "SPADE_UN_28831", "Similarity": 0.6428571428571429, "Sequence": "APRIKKIVQKKLAGD"}, {"SPADE_ID": "SPADE_N_06809", "Similarity": 0.6363636363636364, "Sequence": "NGKKACLNPASPMVQKIIEKIL"}]}}}